Tag: NSCLC,Non-Small Cell Lung Cancer,Press Releases,Veristrat,biomarker,liquid biopsy,lung cancer,molecular diagnostic,personalized medicine
-
Biodesix® and Progenetics Announce Distribution Agreement for Israel
March 9, 2017, Boulder, Colorado…Biodesix, Inc. (Boulder, CO, USA) and Progenetics LTD (Tel Aviv, Israel) announced today that they have entered into an international agreement where Progenetics will market and distribute kits for Biodesix’s GeneStrat® and VeriStrat® liquid biopsy tests for patients with non-small cell lung cancer (NSCLC). Both tests are now available for clinical use…